Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
HIV Medicine|February 10, 2009
Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136)P Yeni, A Lamarca, D Berger, et al.
ESMO Open|March 18, 2026
Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301G K Abou-Alfa, I Borbath, S Roychowdhury, et al.
ESMO Open|April 10, 2021
Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert NetworkG Morgan, M Tagliamento, M Lambertini, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
R-loop landscapes in the developing human brain are linked to neural differentiation and cell-type specific transcriptionElizabeth A LaMarca, Atsushi Saito, Amara Plaza-Jennings, et al.
Translational Psychiatry|April 13, 2026
R-loop landscapes in the developing human brain are linked to neural differentiation and cell type-specific transcriptionElizabeth A LaMarca, Atsushi Saito, Amara Plaza-Jennings, et al.
ESMO Open|June 25, 2026
Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trialA Lamarca, D H Palmer, H S Wasan, et al.
Science (New York, N.Y.)|December 15, 2018
Neuron-specific signatures in the chromosomal connectome associated with schizophrenia riskPrashanth Rajarajan, Tyler Borrman, Will Liao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitorsE S M van Aken, B Devnani, A Prelaj, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
ESMO Open|July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisS Camera, A Vogel, M Rimini, et al.
Pageof 6